To assess the potential of mutations from the L1 loop of the tumour suppressor p53 as second-site suppressors, the effect of H115N and S116M on the p53 'hot spot' mutations has been investigated using the double-mutant approach. The effects of these two mutants on the p53 hot spots in terms of thermal stability and DNA binding were evaluated. The results show that: (i) the p53 mutants H115N and S116M are thermally more stable than wild-type p53; (ii) H115N but not S116M is capable of rescuing the DNA binding of one of the most frequent p53 mutants in cancer, R248Q, as shown by binding of R248Q/H115N to gadd45 (the promoter of a gene involved in cell-cycle arrest); (iii) the double mutant R248Q/H115N is more stable than wild-type p53; (iv) the effect of H115N as a second-site suppressor to restore DNA-binding activity is specific to R248Q, but not to R248W; (v) molecular-dynamics simulations indicate that R248Q/H115N has a conformation similar to wild-type p53, which is distinct from that of R248Q. These findings could be exploited in designing strategies for cancer therapy to identify molecules that could mimic the effect of H115N in restoring function to oncogenic p53 mutants.
INTRODUCTION
The p53 tumour suppressor protein is a key regulator of the signalling pathways implicated in tumorigenesis and presents a classic example of one of the most prevalently mutated proteins in human cancer. In response to various stress stimuli, p53 activates a network of genes involved in cell-cycle arrest, apoptosis and other vital biological processes [1, 2] . In the majority of human cancers, p53 function is abrogated either due to mutations in p53 or elsewhere in the p53 signalling pathway. The latest release of the IARC (International Agency for Research on Cancer) TP53 mutation database contains 26 597 somatic mutations [R14 (release 14), November 2009; http://www-p53.iarc.fr/). Importantly, the p53 mutational status has been associated with poor prognoses in a range of human cancers [3] , and p53 is the most commonly mutated gene in breast and colon cancers [4] . Given that p53 is implicated in over 50 % of all human cancers, it is not surprising that identifying strategies for restoring function to cancer-causing p53 mutations has attracted great interest [1, 2, [5] [6] [7] [8] . The inherent complexities of the p53 functions are reflected in the intrinsic structural organization of the protein. The majority of mutations are found in the p53 DBD (DNA-binding domain), the structure of which was first solved by Cho et al. [9] in 1994. The 'hot spot' residues are the most frequently mutated amino acids in p53 and have been classified as 'contact' (Arg 248 and Arg 273 ) or 'structural' (Arg 175 , Gly 245 , Arg 249 and Arg 282 ) [9] . The structural consequences of the most frequent cancerassociated mutations on the function of p53 have been extensively reviewed [5, 6, 10] . Biophysical, biochemical and functional studies have highlighted the fact that there is no singlebullet approach to restore the function to p53 cancer-associated mutants and that a tailor-made approach has to be applied depending on the intrinsic effect(s) of the individual aminoacid substitution [5, 7, [11] [12] [13] [14] [15] [16] [17] . Mutations in p53 can affect the thermodynamic stability and hence the structural integrity of the p53 DBD (DNA-binding domain) and the conformation for protein-DNA or protein-protein interactions [6, 10, 13, [16] [17] [18] [19] [20] . The thermodynamic stability of p53 mutants itself can vary. Mutants such R248Q and R273H, for example, have a marginal effect on the stability, whereas others (Val 143 ) are dramatically destabilized [13, 16, 17] .
The majority of the mutations are clustered at the protein-DNA-binding interface and tumour-derived mutations in the L1 loop (amino acids 112-124) are not frequently encountered in cancer. Hence the L1 loop has been termed a mutational 'cold spot' [19, [21] [22] [23] . Structurally, the L1 loop is part of the LSH (loop-sheet-helix) motif of the p53 DBD and contains the only three amino-acid residues that directly contact DNA. The DNAcontact residue Lys 120 and Ser 121 are the main residues affected by the conformational change that the loop undergoes upon binding to DNA [5, 24] . Structural studies have shown that the L1 loop is one of the most mobile regions of the core domain and it packs loosely against the core frame with mainly side-chain contacts. Crystal structures of core-domain mutants [5, [25] [26] [27] [28] , and wild-type p53 [29, 30] , indicate some disorder in parts of the L1-loop structure showing structural flexibility. According to MD Abbreviations used: DBD, DNA-binding domain; dsDNA, double-stranded DNA; DTE, dithioerythritol; EMSA, electrophoretic mobility-shift assay; H bond, hydrogen bond; IARC, International Agency for Research on Cancer; MD, molecular dynamics; NMWL, nominal molecular-mass limit; PCA, principal component analysis; R14, release 14; RMSD, root mean square deviation; RMSF, root mean square fluctuation; TB, Tris/borate; T m , melting temperature; TY, tryptone yeast. 1 To whom correspondence should be addressed (email penka.nikolova@kcl.ac.uk).
(molecular dynamics) simulations, residues Leu 114 , His 115 , Ser 116 and Gly 117 make up the most flexible region of the loop [19] . Studies comparing human and worm forms of p53 concluded that loop L1 is one of the most promising regions for stabilization of the p53 structure [31] . Substituting Ser 116 with a methionine residue, without disturbing the wild-type conformation, stabilized the L1 loop. In addition, several studies have reported that some mutations (such as H115N, S121F and T123P) in the L1 loop possess superior binding properties relative to wild-type p53 or altered binding-sequence specificity [21, 23, 32, 33] . A recent report showed that H115N had an enhanced DNA binding, was more effective in inducing p53 target genes (such as p21 and PIG3) as well as arresting cells in G 1 , but was apoptotically impaired when compared with wild-type p53 [21] . Another study employed in vitro compartmentalization to select p53 mutants with altered affinities for p53 response elements associated with the growth-arrest regulator p21 and the pro-apoptotic PUMA gene [34] . Two studies have shown that the T123A mutant increases transactivation in vitro and in vivo, particularly for proapoptotic response elements [23, 34] . Joerger et al. [27] reported that the T123A mutation does not confer any structural changes in the loop L1 region. However, structural studies suggested that residues in loop L1 form part of the p53 dimer-dimer interface [5] . Hence the T123A mutation might contribute to stronger interdomain interactions that stabilize tetramer binding to proapoptotic DNA. In addition to the several mutations in the L1 loop that have previously been reported to enhance the affinity of p53 for specific DNA sequences [21, 32, 33] , others have been identified as second-site suppressors, including T123A [12] . Yet the molecular mechanisms of the latter remain to be elucidated. Different approaches have been exploited to rescue the function of cancer-associated mutants with varied success. The second-site suppressor mutations can rescue the function of some p53 cancerrelated mutants [12, 17, 35, 36] . Recently, the targeted rescue of a destabilized p53 mutant, Y220C, has been investigated by an in silico screening approach [11] . Peptides targeting mutant p53 to induce apoptosis have been employed to inhibit the oncogenic function of mutant p53 [8, 14, 15, 37] .
In the present paper the role of two p53 mutations (H115N and S116M) located in the L1 loop as second-site suppressors has been probed. Key p53 cancer-related mutations alone and as double mutants in combination with one of the two selected L1-loop mutations were used as a model system. The ability of the DNA-contact mutant R248Q, the second most frequent mutation in cancer, which accounts for 855 out of 26 597 of all singlebase substitutions (IARC TP53 mutation database, R14) to bind DNA was restored by introducing H115N. MD complemented the experimental results and provided further insights into the mechanism of rescue of DNA binding by second-site suppressors from the L1 loop.
MATERIALS AND METHODS

Site-directed mutagenesis, and protein expression and purification
Cloning of the sequence coding for the wild-type human p53 DBD (amino acids 94-312) was achieved using the 2.9-kb pRSET(A) expression vector (Invitrogen), which was modified so that it did not have the hexahistidine tags [16, 17, 38, 39] . The p53 mutants were generated using the QuikChange ® site-directed mutagenesis kit (Stratagene). Proteins were expressed in Escherichia coli C41(DE3) cells [39] . Single colonies were selected and added to 5 ml of sterile 2 × TY (tryptone yeast) medium (ForMedium) supplemented with ampicillin (100 μg/ml). The cultures were incubated at 37
• C with shaking at 250 r.p.m. A 5 ml portion of the culture was added to 500 ml of sterile 2 × TY medium containing ampicillin (100 μg/ml) and incubated at 37
• C with shaking at 250 r.p.m. Once a D 600 of 0.6-0.8 was reached, the temperature was reduced to 20 -22 • C and cultures were induced with 1 mM isopropyl β-D-thiogalactoside overnight. The cultures were then centrifuged at 8500 r.p.m. for 25 min at 4
• C. The supernatant was discarded and the cells harvested, frozen in liquid nitrogen and stored at − 80
• C for later use or used for protein purification directly [38, 39] . The protein was released by resuspending and incubating the cell pellets in a mixture of 50 ml of BugBuster ® protein extraction reagent (Merck), 1 tablet of EDTA-free protease inhibitor (Roche) and 5 μl of Benzonase ® nuclease (Merck) per 10 g of cells. The resulting suspension was centrifuged at 13 000 r.p.m. for 25 min at 4
• C. The soluble fraction was collected, from which the protein was purified using an ionexchange, a heparin-affinity and a gel-filtration column connected to anÄKTAprime TM system equipped with PrimeView TM software (all from GE Healthcare).
CD
Protein samples were concentrated to ∼ 0.2 mg/ml using Amicon Ultra-15 centrifugal units, 10 000 NMWL (nominal molecular-mass limit) (Millipore). Buffer was exchanged to 10 mM sodium phosphate, 100 mM NaCl and 4 mM DTE (dithioerythritol), pH 7.2, using Nap-10 Sephadex G25 columns (GE Healthcare). The samples were filtered using 0.2 μm Anatop filters (Whatman). All CD spectra were acquired using an Applied Photophysics Chirascan TM instrument. Suprasil rectangular cells (0.57 mm; Hellma) were used in the far-UV region 260-195 nm. Temperature was controlled using a Melcor thermoelectric Peltier unit. Far-UV CD spectra of the proteins were recorded with a 1 nm spectral bandwidth, a 0.5 nm step size and a 3.0 s time-per-point at 20
• C, 4
• C and 37 • C. Apparent T m s (melting temperatures) of proteins were monitored at a 222 nm wavelength between 20
• C and 60-90
• C. The temperature was increased at a rate of 1 • C/min with a 1
• C step size and a 2 • C tolerance. Measurements were made with a 10 s time-per-point and temperatures measured with a thermocouple probe directly in the protein solution. Far-UV spectra were recorded again after cooling to 20
• C. Spectral results are reported as the difference in the absorbance of right-and lefthanded circularly polarized light, A = (A L − A R ), and converted into the differential molar CD absorption coefficient, ε = (ε L -ε R ), where ε has the unit of litre · mol −1 · cm −1 .
EMSA (electrophoretic mobility-shift assay)
DNA-binding properties of the wild-type and p53 mutants were tested using EMSA and the gadd45 30-mer (forward primer, 5 -GTACAGAACATGTCTAAGCATGCTGGGGAC-3 ; reverse primer, 5 -GTCCCCAGCATGCTTAGACATGTTCTGTAC-3 ).
Freeze-dried single-strand DNA oligos were purchased from Sigma Genosys and resuspended in 10 mM Tris/HCl, pH 8.0, and 100 mM NaCl to give a final concentration of 100 μM. To anneal the oligos, an identical amount of each oligo was mixed in an Eppendorf tube then heated at 99
• C for 5 min and slowly cooled to room temperature (20 • C). For the EMSA studies, 10 μl of protein solution with increasing amounts of protein (1 × , 2 × , 4 × and 8 × 10 −5 M) were titrated into a fixed amount of DNA (5 × 10 −6 M). Each lane in the gel contained 10 μl of 10 −5 M DNA mixed with 10 μl of the protein sample at the concentrations listed above. Proteins were first concentrated using Amicon Ultra-15 centrifugal units, 10 000 NMWL (Millipore). Buffer was exchanged to 50 mM Tris/HCl, pH 7.2, 150 mM NaCl, 4 mM dithiothreitol, pH 7.2, using Nap-10 Sephadex G25 columns (GE Healthcare). The protein solutions were filtered using 0.2 μm Anatop filters (Whatman) and used to prepare 10 μl samples at the required concentrations. After incubation at room temperature for 20-30 min, the mixtures (20 μl each) were run on a 0.7 % agarose gel, in 1 × TB (Tris/borate) running buffer, at 60-90 V for 45-50 min at room temperature to analyse for complex formation. Gels were soaked in 200 ml of water supplemented with 100 μl of 1 mg/ml ethidium bromide and incubated for 20-30 min prior to visualization.
Molecular modelling and MD simulations
The in silico mutants were generated using PyMOL (DeLano Scientific; http://www.pymol.org). As a starting structure, we chose the crystal structure of the human p53 core domain determined in the absence of DNA with the highest resolution available [2.05 Å (1 Å = 0.1 nm); PDB code 2OCJ] [41] . The initial structures of the mutants were energy minimized in vacuo by 1000 steps of the steepest descent method. MD simulations on the wild-type p53 core domain and on the in-silico-generated mutants H115N, S116M, R248Q, R248Q/H115N and R248Q/S116M were performed with the GROMACS package [42] using the 53A6 parameter set of the GROMOS96 force field [43] . The molecules were neutralized with Na + ions (placed following electrostatic potential values) and solvated in boxes containing approx. 13300 SPC (single point charge) water molecules [44] . Initially, water molecules and ions were relaxed by energy minimization and allowed to equilibrate for 200 ps of MD at 300 K with the solute molecules restrained at their initial geometry. The bonds were constrained by the LINCS algorithm [45] with a force constant of 3000 kJ · mol −1 · nm −2 . Finally, the equilibrated systems were subjected to unrestrained MD simulation for 10 ns. Simulations were carried out with periodic boundary conditions at a constant temperature of 300 K. The Berendsen and v-rescale algorithms were applied for pressure and temperature coupling respectively. The PME (particle mesh Ewald method) was used for the calculation of electrostatic contribution to nonbonded interactions (grid spacing of 0.12 nm) [46] [47] [48] . MD trajectories were analysed using GROMACS analysis tools. The Dynamite server (http://www.biop.ox.ac.uk/dynamite) [49] was used to carry out PCA (principal component analysis) of the MD trajectories. Images were produced with Visual Molecular Dynamics software (version VMD 1.8.6) [50] .
RESULTS
Since the majority of the p53 cancer-associated mutants are located in the p53 DBD, a construct containing residues 94-312 was used. The locations of the mutants subjected to the above studies on the three-dimensional structure of p53 are depicted schematically in Figure 1 . We aimed to characterize the folding, stability and DNA-binding properties of H115N and S116M as well as a select set of double mutants generated using key p53 hot spot mutants plus either H115N or S116M and compare them with wild-type p53.
Accessing the folding of the proteins using far-UV CD at different temperatures
In order to access the impact of p53 L1 loop mutants on the oncogenic mutations as well as the folding state of the proteins, both single and double mutants were subjected to detailed far-UV
Figure 1 Ribbon representation of the p53 DBD
The residues mutated in the experiments are highlighted in cyan, while the residues mutated in both experimental and computational studies are shown in blue. The zinc is represented as a purple sphere.
CD scans at various temperatures, namely 4, 20 and 37
• C, and cooling to 20
• C after heating to 37
The results for the wildtype p53 and the single mutants are presented in Figure 2 and those for the double mutants in Figure 3 . The far-UV CD spectrum of wild-type p53 DBD has been recorded previously [38] and was used in the present study as control in order to compare it with the mutants of interest (Figure 2A ). The spectra of wild-type p53 DBD at 20
• C and 4
• C are essentially identical, but differ from the spectra recorded at 37
• C. This implies that at 37
• C wild-type p53 DBD has undergone partial unfolding, which is irreversible upon cooling back to 20
• C (results not shown). The spectra of H115N and S116M are shown in Figures 2(B) and 2(C). The H115N mutant is similar to the wild-type p53 since the scans at 20
• C and cooling back to 4 • C are virtually identical, but they differ from the spectra recorded at 37
• C. However, S116M shows almost identical scans at all the temperatures tested ( Figure 2C ). The scans indicate that the conformations for H115N and S116M are different from that of the wild-type p53 protein at 20
• C (Figures 2A, 2B and 2C) . The results for the cancer-associated mutations, namely R248Q, R248W, R249S, R273H, V143A and G245S, are shown in Figures 2 (D-I) respectively.
The variable-temperature far-UV CD spectra for the corresponding double mutants recorded under the same conditions are displayed in Figure 3 . As shown in Figures 3(A) and 3(B) , the spectra of R248Q/H115N and that of R248Q/S116M at 20
• C, then at 4
• C and 37
• C, basically overlapped. Interestingly, the spectra of the oncogenic mutant R248Q ( Figure 2D ) differ from that of the double mutant R248Q/H115N ( Figure 3A) . Specifically, the scans at 37
• C are nearly identical with those recorded at 20
• C and at 4
• C for the double mutant versus R248Q alone. Similar observations were seen for R273H ( Figure 2G ) versus the double mutant R273H/H115N ( Figure 3E ). On the other hand, the spectra for R249S ( Figure 2F ) when compared with those of the double mutants R249S/H115N ( Figure 3G ) and R249S/S116M ( Figure 3H ), seemed to suggest that both the single and double mutants undergo unfolding at 37
• C. The scans for R248W ( Figure 2E ) and that of R248W/H115N ( Figure 3C ) are almost identical but different to R248W/S116M (Figure 3D) , where all scans overlapped, suggesting that the latter double mutant seems to be folded at physiological temperature, consistent with the observation for the double mutant R248Q/S116M ( Figure 3B ). The spectra for G245S and G245S/H115N are only slightly different at all temperatures tested ( Figure 2I and Figure 3J) . Reviewing the CD results allows the classification of the p53 proteins studied in the present work into two groups: those with a conformation similar to wild-type p53, R248Q, R248W, R249S, R273H, R248W/H115N, R273H/H115N, R273H/ S116M, R249S/S116N, R248Q/H115N and V143A/H115N, and those that differ from the wild-type p53 conformation, namely H115N, S116M, V143A, G245S, R248W/S116M, R248Q/S116M, G245S/H115N and R249S/H115N.
Thermal stability of the p53 cancer-associated mutants and the second-site suppressors relative to the corresponding double mutants
The selection of mutant proteins studied in the present work is an illustrative example of the intrinsic complexities of p53 protein. The thermal melting curves of p53 showed broadly two different phenomena: unfolding and aggregation. The thermal stability of wild-type p53 is around 42
• C (Figure 4 ), which is in good agreement with previously published results for the same construct [13, 16, 38] . Wild-type p53 is relatively conformationally stable between 4
• C and 32 • C. Between 32 • C and 38
• C, there is evidence of unfolding; above 38
• C, p53 forms irreversible aggregates with an apparent T m of ∼ 42
• C. The H115N single mutant shows changes only above 32
• C that cannot be readily distinguished from the aggregation stage that gives a T m of ∼ 42.4
• C (Figure 4) . The S116M single mutant shows no evidence of change until 40
• C. Above 40
• C, only the aggregation step is observed with a T m of ∼ 43.3
• C (Figure 4) . The R248Q single mutant is relatively unchanged until 34
• C; the ensuing dominant aggregation has a T m of ∼ 43.4
• C. The R273H mutant (Figure 4) is stable up to 38
• C; higher temperatures showed only the aggregation step with a T m of ∼ 41.3
• C. The V143A single mutant (Figure 4) is stable up to 25
• C, when a pronounced unfolding stage is observed with the onset of aggregation at 33
• C, giving a T m of ∼ 37
• C. The R248Q/H115N double mutant is stable (Figure 4 ) until 33
• C, at which point unfolding occurs; aggregation sets in at 42
• C, giving a T m of ∼ 44.4
• C. The R248Q/S116M double mutant is markedly stable up to 38
• C, at which point a pronounced unfolding stage occurs followed by the aggregation onset at 44
• C, giving a T m of ∼ 46.1 • C (Figure 4) . The R273H/S116M double mutant (Figure 4 ) appears to be the least flexible mutant in this set and the most resistant to aggregation. Unfolding commences at 36
• C with evidence of aggregation beginning at 43
• C. The R273H/H115N double mutant (Figure 4 ) is also very stable up to 40
• C. There is no evidence of unfolding before the aggregation step, which commences at 40
• C, giving a T m of ∼ 42.7
• C. The V143A/H115N double mutant (Figure 4) shows a minor hint of unfolding starting at 27
• C, with the aggregation process commencing at 33
• C, with a T m of ∼ 38 • C. Interestingly, the two mutants from loop L1 H115N and S116M displayed higher thermal stability than wild-type p53 DBD (Figure 4) , as is obvious from the melting curves. Most notably, the double mutant R248Q/H115N exhibited higher stability relative to the cancer-associated mutant R248Q, as well as wild-type p53. Some cancer-associated mutants, such as V143A (Figure 4 ) and R249S (results not shown) for example, exhibit a lower apparent melting temperature, while others such as R273H (Figure 4 ) or G245S (results not shown) are only marginally less stable than the wild-type p53 DBD. The double mutants R273H/H115N and R273H/S116M (Figure 4 ) appear to be more stable that the • C, that of R273H from approx. 41.3 to 42.7
• C, and that of R248Q by approx. 1 • C. Furthermore, thermal destabilization was reported to correlate well with enhanced kinetics of unfolding at 37
• C [51] , namely mutants such as V143A and R249S unfolding an order of magnitude faster than wild-type p53, while R273H and G245S unfold only slightly faster. Importantly, unfolding is associated with the aggregation of mutants at 37
• C, i.e. the higher the unfolding the faster the aggregation.
Investigating the DNA-binding of the p53 mutants by EMSA
Having assessed the folding state and the thermal stabilities of the proteins, we employed EMSA assays as a simple and effective way to screen for DNA-binding activities. We selected the 30-mer gadd45 dsDNA (double-stranded DNA) as a model system since it is known that it binds to the wild-type p53 core-domain protein. The results of these tests are shown in Figure 5 and in Supplementary Figure S1 available at http://www.BiochemJ.org/ bj/427/bj4270225add.htm. The binding of wild-type p53 DBD ( Figure 5A , lanes 2-5) and the two single mutants from the L1 loop, H115N ( Figure 5A , lanes 7-10) and S116M ( Figure 5A , lanes 12-15) showed essentially similar binding properties to gadd45 dsDNA. Lanes 1, 6 and 11 showed free DNA as a control. The cancer-associated hot spot mutants, the double mutants containing the cancer hot spots plus either the H115N or the S116M were tested by the same method ( Figures 5B-5F ). Remarkably, the double mutant R248Q/H115N ( Figure 5B , lanes 12-15) exhibited a recovery for DNA binding to gadd45, which was almost similar to that of wild-type p53 DBD ( Figure 5B,  lanes 2-5) . The addition of the second-site mutation H115N rescued the DNA binding of the R248Q, one of the most mutated residues in cancer, which, as shown on Figure 5 (B), lanes 7-10, does not bind to DNA on its own. The rescue effect is specific since the addition of S116M to R248Q or R248W did not rescue the DNA binding of the cancer hot spots, as is obvious from Figures 5(C) and 5(D). We also tested the structural mutant R249S, which does not bind DNA on its own (Figures 5E and 5F, lanes 7-10 respectively). However, H115N and/or S116M did not have any apparent effect on the DNA binding of the corresponding double mutants R249S/H115N ( Figure 5E , lanes 12-15) and R249S/S116M ( Figure 5F, lanes 12-15) . Similarly, the effect of H115N on V143A, G245S and R273H was also tested (results not shown). Although H115N enhanced the DNA binding of V143A and G245S, which already showed partial DNA binding, the effect was not as dramatic as that of the R248Q. However, H115N did not result in enhanced DNA binding when included as part of the double mutant R273H/H115N. Similarly the addition of H115N to R248W (Supplementary Figure S1 , lanes 7-10) does not have any apparent effect on the DNA binding as is obvious from the EMSA gel, which shows some marginal partial binding for R248W, similar to that of the double mutant R248W/H115N (Supplementary Figure S1, lanes 12-15) .
Modelling the structures of H115N, S116M, R248Q, R248Q/H115N and R248Q/S116M, and analysis of their conformational behaviour
To gain structural insights of the p53 L1 loop mutants, H115N and S116M, and their effect as potential second-site suppressors, we performed MD simulations. These produced stable trajectories as shown by macroscopic properties of the systems, such as potential and total energies (results not shown). The time evolution of the RMSD (root mean square deviation) values with respect to starting structures indicates that the proteins have reached stable structures (within 3.0 Å from the initial state) during the 10-nslong MD simulations (see Supplementary Figure S2 available at http://www.BiochemJ.org/bj/427/bj4270225add.htm). First, we focused on H115N and S116M, to evaluate their effect on the region critical to DNA binding and their overall effect on the stability of the p53 DBD. The trajectories of the wild-type and the two single L1 loop mutants were compared based on the residue RMSFs (root mean square fluctuations) calculated over the last 4 ns of each simulation ( Figure 6 ). The RMSF plots showed a similar pattern, but the mutants were generally fluctuating less than the wild-type. In particular, differences were observed in the fluctuations of the L1 and L2 loops, and in the region connecting H1 and S5.
To analyse the stability of the L1 loop and its conformational changes during the trajectories, we calculated for the last 4 ns of each trajectory the number of H bonds (hydrogen bonds) formed by residues of the L1 loop and S2 structural elements (the stretch of residues 113-126), as well as the number of H bonds formed between this stretch and the H2 helix residues (residues 277-289) ( remained stable. As a result the average L1-H2 H-bond number over the last 4 ns of simulation was reduced to one. As shown in Table 1 , when His 115 is changed to an asparagine residue the number of H bonds between the loop region and the H2 helix remains unaltered, while resulting in an increase of a total of five H bonds in the loop region. His 115 is oriented towards the solvent in the wild-type crystal structure and in the MD simulation, not forming any intramolecular interactions. In the H115N Figure 6 ) shows that, despite there being fewer H bonds within the loop, the mutation seems not to disrupt the L1 conformation (in agreement with the results of Pan et al. [19] ). On the contrary, the mutation seems to diminish its conformational flexibility, reducing the fluctuations and increasing the interactions of the loop with the neighbouring H2 helix. The overall result from the analysis of the point mutants, H115N and S116M, is that they substantially preserve the native conformation of the L1 loop and decrease its fluctuation. H115N increases the number of intraloop H bonds, whereas S116M increases the number of loop-helix H bonds. These results show that the mutant H115N is stabilized intramolecularly and kept more rigid in a conformation that is more suitable for DNA binding, as hypothesized in the literature [21] . We examined R248Q to assess the effect of this mutation on the p53 core domain. Visual inspection of the trajectory and the PCAs (see supplementary Movie S1 available at http://www.BiochemJ.org/bj/427/bj4270225add.htm) revealed that the mutation of residue Arg 248 causes not only a rearrangement of the L3 loop, but a consequent rearrangement of the whole region of the protein involved in binding to DNA. Indeed, once mutated, the L3 loop is freer to move because the repulsion previously present between Arg 248 and Arg 273 is eliminated. In addition, the Arg 273 , linked to the H2 helix by means of a salt bridge with Asp 281 , gains interactions with serine residues of the L3 loop (Ser 240 and Ser 241 ) inducing a displacement of the H2 helix from its original positioning. The movement of the L3 loop also generates a rearrangement of the nearby loop connecting S7 and S8. The net effect of these rearrangements is that the L1 loop moves away from the H2 helix as shown in Figures 7(A) and 7(B) . The distance between the Cα atom of residue 248 and the Cα atom of the closest residue of H2 (residue 285) was calculated to decrease from 15 Å to 12.5 Å. The distance between the Cα atoms of residues 279 and 118 (the two closest residues in the starting structure belonging to the H2 helix and the L1 loop respectively) increased from 3.8 Å to 14.4 Å. This concerted movement also results in the loss of H bonds formed between the loop region and the helix ( Table 1 ).
The complex structural rearrangement caused by a single change in the amino-acid sequence complement previous observations that R248Q behaves as both a contact and structural mutant [52] . Finally, we examined the two double mutants R248Q/H115N and R248Q/S116M to evaluate the effect of concerted mutations on the L1 loop positioning. Figure 7(C) shows the final structures of R248Q/H115N and R248Q/S116M superimposed on to the structure of the wild-type p53 core domain. The direct comparison of the structures shows clearly that the final structure of the R248Q/H115N mutant remains close to the wild-type structure. On the other hand, the final structure of R248Q/S116M resembles better the one obtained for the R248Q simulation. To analyse in detail the behaviour of the L1 loop, we computed the RMSD of Cα atoms of the loop (residues 113-123) for the native structure and the mutants R248Q/H115N and R248Q/S116M ( Figure 7D ). The plot shows that the structural positioning observed for the L1 loop of R248Q/H115N is comparable with the wild-type, whereas the R248Q/S116M mutant shows a remarkable structural deviation in the L1 region. The calculation of the number of H bonds reveals that there are five intraloop H bonds in the L1 loop of R248Q/H115N, as observed for the single mutant H115N. In particular, three out of these five H bonds are the same as those formed in the wild-type structure, and the other two are the same as those formed by Asn 115 in the H115N mutant. For R248Q/S116M, we observed a large conformational change in the L1 region that allowed His 115 (orientated towards the solvent in the crystal structure and in all the other simulated structures) to form two H bonds, one with Gly 117 and one with Ala 119 . As for the R248Q mutant, no interactions were found between the L1 loop and the H2 helix, confirming similar conformational behaviours for these two mutants. Overall, the R248Q mutation causes a large rearrangement of the protein in the region involved in the binding of the DNA and especially in the L1 loop. The original position of the L1 loop is not restored in R248Q/S116M, but is restored in R248Q/H115N owing to the presence of the asparagine residue that stabilizes the loop intramolecularly by forming two extra intraloop H bonds.
DISCUSSION
Several studies have highlighted the importance of the L1 loop as a highly modular region in the p53 structure, which is rarely mutated in cancer. Results from yeast-based, cell-free or cellbased assays, in addition to MD simulations, have suggested a role for the L1 loop in the recognition of specific DNA sequences, transactivation and apoptosis by p53 [19, 22, 23, 33, 34] . To clarify further the intrinsic role of the mutations located in the L1 loop on the conformation, thermal stability and DNA binding of the protein, we performed detailed biophysical, biochemical and structural studies complemented with MD simulations using mutations H115N and S116M as a model. The experimental CD results showed that the two mutants are more thermally stable than the wild-type p53. This observation was based on the apparent T m s of the mutant proteins and was in good agreement with our MD-simulation results. Pan et al. [19] have reported similar observations for S116M during systematic computational mutagenesis of the L1 loop. Ser 116 was selected as a representative residue of the L1 loop and mutated to 14 other amino-acid residues. All mutants were subjected to MD simulations, with S116M exhibiting the highest stability largely owing to the reduced conformational flexibility of the L1 loop. These computational studies complement our previous experimental finding that the 'super-stable' p53 mutant M133L/V203A/N239Y/N268D exhibited 2.6 kcal/mol higher thermodynamic stability than the wild-type p53 DBD [16] . The crystal structure of the super-stable mutant revealed that the enhanced thermodynamic stability is due to the more rigid structure (reduced plasticity) and provided insights into the mechanism of rescuing p53 oncogenic mutations [25] . It was reported that changes in the thermodynamic stability of p53 were associated with reduced levels of folded and hence functional p53 [53] . The thermal behaviour of p53 and some of its mutants has been previously monitored by differential scanning calorimetry and fluorescence [13, [16] [17] [18] . The present study employed CD. The apparent T m s for all proteins of interest were measured by CD at 222 nm in order to obtain semi-quantitative measures about their thermal stabilities and flexibilities. Since all of the proteins unfold irreversibly, the thermal melting curves are still a useful way to provide an assessment of the thermal stability of the mutants. The first thermal step involves a secondary-structure change, which relates to the flexibility of the proteins. The second step at higher temperatures involves irreversible aggregation. Which of the two processes need to be addressed to reverse mutant-induced loss of DNA binding is open to question. Characterizing the first unfolding stage is difficult as it is immediately followed by an irreversible aggregation stage that dominates the thermal studies and is largely responsible for the apparent T m . Pan et al. [19] showed that the 14 designed mutants displayed a wide range of stabilities, ranging from completely destabilized, such as S116P and S116C, to highly stabilized, such as S116M, S116L and S116N. Only S116M was predicted to be capable of substantially preserving the native conformation of the mobile L1 loop of p53 DBD. Given that wild-type p53 is only moderately stable [13, 54, 55] , the quest for generating more-stable p53 variants has been considerable, since it has implications in designing strategies for cancer therapies. The ultimate aim is not only to design a more thermodynamically stable protein, but also a properly folded and functionally active protein that is capable of binding to DNA (i.e. p53 response elements). To explore this aspect further, we investigated the DNA-binding properties of H115N and S116M using gadd45 as a model DNA-binding sequence specific for p53. Our findings showed that both mutants from the L1 loop bind to the DNA with similar affinity to that of the wild-type p53. It was reported that several mutations located in the L1 loop enhance the affinity of p53 for a select set of DNA sequences [22, 23, 33] . For instance, the S121F mutant is known to induce apoptosis more effectively than wild-type p53 and to exhibit an increased affinity for some p53-binding sites. In a more recent report, Fen et al. [34] selected p53 mutants that display altered DNA-binding specificities. Interestingly, the evolved variants contained substitutions in the L1 loop of the p53 DBD, which showed increased transactivation of promoters and increased up-regulation of endogenous p21 relative to wildtype p53. Zupnick and Prives [23] reported that T123A showed strikingly different and stronger affinity for p53 response elements and that the mutant caused enhanced apoptosis relative to wildtype p53 in transfected cells. However the molecular mechanisms of the above effects are not clear.
Building on the above knowledge and our results for H115N and S116M, we applied the second-site suppressors or 'doublemutant-cycle' approach to test the effect of the above two mutants on the stability and DNA binding of key cancer-associated mutants. Specifically, we aimed to investigate whether these two mutants from the L1 loop would have any compensatory effect on the stability of the cancer-related mutants or trigger conformational changes on the latter or both. Strikingly, our studies revealed that the double mutant R248Q/H115N exhibited DNA binding for gadd45. This finding is significant given that R248Q, one of the most mutated residues in cancer and one of the only two DNA-contact mutants, does not exhibit DNA binding on its own. Furthermore, the observed effect is specific to R248Q, since the double mutant R248W/H115N does not seems to show enhanced DNA binding when compared with R248W under similar conditions tested. Similarly, neither R248Q/S116M nor R248W/S116M showed any DNA binding for the same DNA sequence. In the absence of a crystal structure of the above mutants, we performed MD simulations of the two mutants of the L1 loop, H115N and S116M, as well as of the two double mutants, R248Q/H115N and R248Q/S116M, to gain further understanding of the molecular mechanism of restoring DNA binding to R248Q by H115N. These results showed that R248Q/H115 indeed is structurally more similar to wild-type p53 than R248Q/S116M.
From the computational data, we observed that R248Q has a similar conformation, especially in the L1 loop, with the double mutant R248Q/S116M, for which DNA binding was not restored. It should be noted that R248Q is unusual in that it is more than just a 'contact' mutant since it is not hugely destabilized (1.9 kcal/mol less stable than wild-type p53), but the structures of loops L2 and L3 are perturbed [13, 52] . We applied the same experimental tests to a selection of other cancer mutants such as V143A, G245S, R249S and R273H. All of these four mutants are very different structurally and have different DNA-binding, as well as thermodynamic, properties. For example, V143A is a temperature-sensitive mutant and has partial DNA binding, G245S is a structural mutant that is moderately destabilized relative to wild-type p53 and has partial DNA binding, whereas R249S has no DNA binding and is less stable than wild-type p53 [13, 17, 34] . R273H has an almost similar stability to that of wildtype p53 and, despite the removal of an essential DNA-contact residue Arg 273 , has some partial DNA binding. A recent X-raystructure study attributed this to the localized structural changes, which do not perturb the overall scaffold of the DNA-binding surface [6] . It was also shown that global suppressors such as N239Y and N268D rescued the function of G245S and V143A [12, 17] . This was ascribed to an increase of the thermodynamic stability of N239Y and N268D resulting in the compensatory effect of rescue of the cancer-associated p53 mutations [16, 17] . In addition, it has been reported that the function of G245S has been rescued by the second-site suppressor H178Y in an intermolecular manner [36] . The function of R249S was rescued by H168R, and NMR studies showed that this was due to the induced conformational effects created by H168R rather than the increase of stability [17] . Structural studies have also revealed that R249S induces conformational changes and greater flexibility in loop L3, which results in a loss of stability and DNA binding. The function of Y220C, which accounts for a large number of human cancers, was rescued by a small drug that fills the cleft created by the point mutation, creates a surface cavity and destabilizes the protein [11] .
The experimental and computational studies reported in the present study show that mutants H115N and S116M from the L1 loop stabilize the overall conformation of p53 DBD while at the same time maintaining DNA binding for p53 response elements. Mutant H115N rescued the binding of the oncogenic mutant R248Q for gadd45 dsDNA. Further structure-function studies of R248Q/H115N, R248Q and the H115N would provide clues into the mechanism of rescue of R248Q. It is envisaged that screening libraries of small molecules would identify candidates that mimic the effect of the second-site suppressors and could be exploited in cancer therapy or as prototypes for structurebased drug design. Reactivation of cancer-associated mutants remains an important approach in designing strategies for cancer therapies. Better understanding of the molecular mechanism of mutant reactivation by second-site suppressors has the potential to provide new insights leading to novel drug developments. 
